ClinConnect ClinConnect Logo
Search / Trial NCT04754269

A Mobile Health Intervention to Reduce Sweet Beverage Consumption in Latino Children

Launched by UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · Feb 10, 2021

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is looking at ways to help Latino children aged 1 to 5 drink fewer sugary beverages and to encourage parents to read aloud to their children more often. Drinking too many sugary drinks can lead to serious health issues like obesity and diabetes, and many Latino children are at a higher risk for these problems. The study aims to see if two mobile health programs can help parents improve their children's drink choices and increase the amount of reading done at home.

To participate in this study, parents must identify their child as Latino and have a child between 1 to 5 years old. They also need to have a cell phone that can receive text messages and be able to speak either English or Spanish. Throughout the trial, families will receive helpful tips and support through their phones to make these positive changes. This is a great opportunity for families to contribute to important research while also gaining tools to promote healthier habits and early literacy in their children.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Parent identifies child as Latino/a/x
  • Child age 1 to 5 (12 to 59 months)
  • Parent has a cell phone that can receive text messages
  • Parent speak English or Spanish
  • Exclusion Criteria:
  • • Child does not feed by mouth

About University Of California, San Francisco

The University of California, San Francisco (UCSF) is a leading academic institution renowned for its commitment to advancing healthcare through innovative research and clinical trials. With a focus on translating scientific discoveries into effective therapies, UCSF collaborates with a diverse array of stakeholders, including healthcare professionals, industry partners, and patient communities. The university's research programs emphasize interdisciplinary approaches and leverage cutting-edge technology to address complex medical challenges. As a sponsor of clinical trials, UCSF is dedicated to maintaining the highest standards of ethical conduct and scientific rigor, ensuring the safety and well-being of participants while contributing to the broader medical knowledge base.

Locations

San Francisco, California, United States

Patients applied

0 patients applied

Trial Officials

Amy L Beck, MD, MPH

Principal Investigator

University of California, San Francisco

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials